Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
Ital J Pediatr
; 48(1): 76, 2022 May 16.
Article
em En
| MEDLINE
| ID: mdl-35578294
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Asma
/
COVID-19
/
Anafilaxia
Tipo de estudo:
Guideline
/
Risk_factors_studies
Limite:
Child
/
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article